Medical device company Avita Medical Ltd. (AVMXY.OB) has been awarded a 5-year, $53.9 million contract by the Biomedical Advanced Research and Development Authority for the company’s late-stage clinical development and procurement of ReCell Autologous Cell Harvesting Device, under a U.S. mass casualty preparedness program.